Back
Population Data-Driven Formulation of a COVID-19 Therapeutic
Campbell, H. R.; Cecil, R. P.; Lodder, R.
2020-07-27
infectious diseases
10.1101/2020.07.24.20161547
medRxiv
Show abstract
This study is designed to utilize computer modeling of the US population through NHANES to reduce the need for preclinical formulation and toxicology studies of an Ebola anti-viral (BSN389) being repurposed for COVID-19, and to thereby speed the candidate therapeutic to the clinic.
Matching journals
●Non-profit
◐University press
○Commercial
The top 13 journals account for 50% of the predicted probability mass.
1
PLOS ONE
●
5266 papers in training set
Top 13%
13.9%
Similar papers in this journal
- How important are concurrent vehicle control groups in (sub)chronic non-human primate toxicity studies conducted in pharmaceutical development? An opportunity to reduce animal numbers 92%
- Distinguishing classes of neuroactive drugs based on computational physicochemical properties and experimental phenotypic profiling in planarians 91%
- Exploring NCATS In-House Biomedical Data for Evidence-based Drug Repurposing 91%
2
PLOS Global Public Health
●
344 papers in training set
Top 3%
5.9%
Similar papers in this journal
- Adverse Drug Reactions in Tuberculosis Treatment: Incidence, Reporting and Outcomes; Insights from a Mixed-Methods study across eight Indian cities 88%
- Drug Supply Management at First-level Public Health Facilities: Case of Pyay District, Myanmar 88%
- Recording vaccine doses administered: A global analysis of tally sheet design for infant and child immunizations 87%
4
Scientific Reports
○
3612 papers in training set
Top 23%
4.3%
Similar papers in this journal
- Probenecid Inhibits SARS-CoV-2 Replication In Vivo and In Vitro 90%
- Determinants of cardiac adverse events of chloroquine and hydroxychloroquine in 20 years of drug safety surveillance reports 90%
- A new strategy for identifying mechanisms of drug-drug interaction using transcriptome analysis: Compound Kushen injection as a proof of principle 90%
5
Annals of Internal Medicine
●
28 papers in training set
Top 0.1%
4.3%
Similar papers in this journal
- Assessing Durability of Vaccine Effect Following Blinded Crossover in COVID-19 Vaccine Efficacy Trials 87%
- Effectiveness of COVID-19 treatment with nirmatrelvir-ritonavir or molnupiravir among U.S. Veterans: target trial emulation studies with one-month and six-month outcomes 87%
- The incubation period of 2019-nCoV from publicly reported confirmed cases: estimation and application 87%
50% of probability mass above
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.